Madrigal Pharma's REZDIFFRA sees 33% Q1 2025 sales growth, strong EU progress, and promising MASH data. Read why I maintain ...

While GitLab took a beating from its Q2 sales guidance downgrade, the statistical backdrop of GTLB stock presents an enticing ...

US data center firm EdgeMode has announced the acquisition of Synthesis Analytics Production Ltd. (SAPL), which will now be ...

Going back to PLTR stock, its trailing-two-month price action can be converted as a 4-6-U sequence. Based on past analogs, we ...

Innovent Biologics is pivoting to R&D and oncology growth in China, but high valuation and risks temper upside. Read why ...

Alignment and sequencing errors are a major concern in molecular evolution, and this valuable study represents a welcome improvement for genome-wide scans of positive selection. This new method seems ...

The novel cue-induced analgesia paradigm allowed a compelling identification of a brainstem circuit element, i.e., somatostatin-expressing neurons within the ventrolateral periaqueductal grey that ...

We're flying as fast as time travels around the clock toward the ban on social media for kids under 16 and there are still a ...

CSL Behring Germany today announced that the first haemophilia B patient in Germany was treated with the gene therapy HEMGENIX® (etranacogene dezaparvovec) at the Hemophilia Treatment Center at ...

Social media listening becomes a ritual of collection without integration. Engagement metrics are tracked, but not interpreted. We also have to talk about platform bias. Not every customer is on ...

Nowhere is this more evident than in India’s expanding metadata surveillance regime, which operates largely in legal opacity and bureaucratic silence. While traditional surveillance has always been a ...

As Monash's partnership with Woodside comes up for renewal, the university is facing pressure from students and staff to ditch the company for good.